Search
for
Sort by
Research 31–60 of 781
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Under Development JAK Inhibitors for Dermatologic Diseases
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- New drugs under investigation for the treatment of alopecias
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Effects of Periplaneta americana extracts on the growth and proliferation of cutaneous interstitial cells in cutaneous-wound healing
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Phytochemicals for Hair Health Targeting Growth Signaling Molecules in Hair Follicular Stem Cells: A New Strategy for Hair Growth
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)